🇺🇸 HUMAN IMMUNOGLOBULIN G in United States

25,228 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 4,238 reports (16.8%)
  2. Fatigue — 2,779 reports (11.02%)
  3. Covid-19 — 2,724 reports (10.8%)
  4. Headache — 2,513 reports (9.96%)
  5. Drug Ineffective — 2,344 reports (9.29%)
  6. Sinusitis — 2,281 reports (9.04%)
  7. Pneumonia — 2,279 reports (9.03%)
  8. Product Dose Omission Issue — 2,146 reports (8.51%)
  9. Inappropriate Schedule Of Product Administration — 2,135 reports (8.46%)
  10. Malaise — 1,789 reports (7.09%)

Source database →

HUMAN IMMUNOGLOBULIN G in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is HUMAN IMMUNOGLOBULIN G approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for HUMAN IMMUNOGLOBULIN G in United States?

Marketing authorisation holder not available in our data.